Geraldine Goss

1PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jul 24, 2025
Durvalumab versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): A Multicenter, Randomized, Phase 2 Trial.

Natalie Y L Ngoi, Chel Hun Choi, Junxian Zhu

Pageof 1

Frequent Collaborators

1 joint publications

Natalie Y L Ngoi

1 joint publications

Chel Hun Choi

1 joint publications

Junxian Zhu

1 joint publications

Diana Lim

1 joint publications

Tuan Zea Tan

1 joint publications

Haoyang Sun

1 joint publications

Valerie Heong

1 joint publications

Samuel G W Ow

1 joint publications

Wen Yee Chay

1 joint publications

Hee Seung Kim

Frequent Collaborators

1 joint publications

Natalie Y L Ngoi

1 joint publications

Chel Hun Choi

1 joint publications

Junxian Zhu

1 joint publications

Diana Lim

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
05:35

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

Published on : Sep 15, 2023

1.6K
See more related videos

Top Related Videos

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
05:35

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

Published on : Sep 15, 2023

1.6K
See more related videos